AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12752398 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular infusion of a combination of bradykinin, serotonin, histamine, and prostaglandin E2
Number of subjects: 15
Study 12752398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 10841243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous heparin 6 h postoperatively
Number of subjects: 49
Study 10841243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous heparin 24 h postoperatively
Number of subjects: 49
Study 10841243 — intervention group
Group type: COMPARATOR
Intervention: Warfarin alone
Number of subjects: 49
Study 10841243 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 49
Study 9506008 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone transdermal system applied to upper buttocks
Number of subjects: 13
Study 9506008 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone transdermal system applied to upper arm
Number of subjects: 13
Study 9506008 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone transdermal system applied to back
Number of subjects: 13
Study 8432275 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 20 micrograms/kg
Number of subjects: 45
Study 8432275 — intervention group
Group type: EXPERIMENTAL
Intervention: lignocaine 1.5 mg/kg
Number of subjects: 45
Study 8432275 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 45
Study 3099487 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nitroglycerin per day
Number of subjects: 12
Study 3099487 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nitroglycerin per day
Number of subjects: 12
Study 3099487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 28753047 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-Based Learning (TBL) with guided reflection and feedback on the team leadership process
Number of subjects: 39
Study 28753047 — intervention group
Group type: COMPARATOR
Intervention: Team-Based Learning (TBL) only
Number of subjects: 39
Study 28753047 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretest intervention group
Number of subjects: 39
Study 28753047 — intervention group
Group type: COMPARATOR
Intervention: Pretest control group
Number of subjects: 39
Study 28753047 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttest intervention group
Number of subjects: 39
Study 28753047 — intervention group
Group type: COMPARATOR
Intervention: Posttest control group
Number of subjects: 39
Study 27397669 — intervention group
Group type: EXPERIMENTAL
Intervention: Sniffing position with a pillow of 7 cm
Number of subjects: 18
Study 27397669 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated sniffing position with a pillow of 10 cm
Number of subjects: 18
Study 27397669 — intervention group
Group type: COMPARATOR
Intervention: Simple head extension without a pillow
Number of subjects: 18
Study 23939953 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 585
Study 23939953 — intervention group
Group type: EXPERIMENTAL
Intervention: Emtricitabine (FTC)/TDF
Number of subjects: 585
Study 23939953 — intervention group
Group type: COMPARATOR
Intervention: TDF monotherapy
Number of subjects: 585
Study 22750852 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie milkshake preload
Number of subjects: 118
Study 22750852 — intervention group
Group type: COMPARATOR
Intervention: Non-caloric drink preload
Number of subjects: 118
Study 22750852 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-reinforcement task
Number of subjects: 118
Study 20009790 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative sizing with silicone implant samples
Number of subjects: 567
Study 20009790 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative sizing)
Number of subjects: 567
Study 19213351 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Chinese and Western medicine treatment including Chinese recipe decoction (500 mL for hip bathing 5-10 min every night) and local application of Jingan oil (twice daily) for 2 months.
Number of subjects: 100
Study 19213351 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with local application of Jingan oil and hip bathing with warm water for 2 months.
Number of subjects: 100
Study 16078300 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhomboid excision and the Limberg flap procedure (group 2)
Number of subjects: 200
Study 16078300 — intervention group
Group type: COMPARATOR
Intervention: Excision and primary closure (group 1)
Number of subjects: 200
Study 11839368 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 45
Study 11839368 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 45
Study 11839368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 10444121 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined optical mechanical cystolithotripsy (OMC) and transurethral prostatectomy (TURP)
Number of subjects: 61
Study 10444121 — intervention group
Group type: EXPERIMENTAL
Intervention: OMC alone
Number of subjects: 61
Study 10444121 — intervention group
Group type: COMPARATOR
Intervention: TURP alone (control)
Number of subjects: 61
Study 10444121 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined OMC and TURP
Number of subjects: 61
Study 8595172 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg of ZD1033 daily for 10 days
Number of subjects: 0
Study 8595172 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of ZD1033 daily for 14 days
Number of subjects: 0
Study 8595172 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg of ZD1033 daily for 14 days
Number of subjects: 0
Study 8595172 — intervention group
Group type: COMPARATOR
Intervention: Standard ACTH challenge
Number of subjects: 0
Study 1815819 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental inactivity (eyes closed)
Number of subjects: 10
Study 1815819 — intervention group
Group type: COMPARATOR
Intervention: Mental arithmetics (eyes open)
Number of subjects: 10
Study 6119492 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative parenteral nutrition (PPN) for 10 days
Number of subjects: 125
Study 6119492 — intervention group
Group type: COMPARATOR
Intervention: Regular hospital diet (Control)
Number of subjects: 125
Study 31494273 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 IU of oxytocin nasal spray
Number of subjects: 80
Study 31494273 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 80
Study 30999057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 198
Study 30999057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.2 mg/kg
Number of subjects: 198
Study 30999057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 27492419 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient-dense oral nutritional supplement (ONS) containing high protein and β-hydroxy-β-methylbutyrate
Number of subjects: 0
Study 27492419 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 27492419 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient-dense oral nutritional supplement (ONS)
Number of subjects: 0
Study 26717219 — intervention group
Group type: EXPERIMENTAL
Intervention: Mozart music
Number of subjects: 60
Study 26717219 — intervention group
Group type: COMPARATOR
Intervention: Beatles music
Number of subjects: 60
Study 26717219 — intervention group
Group type: COMPARATOR
Intervention: Radio news
Number of subjects: 60
Study 23212610 — intervention group
Group type: EXPERIMENTAL
Intervention: CR665 (0.36 mg/kg, intravenous)
Number of subjects: 0
Study 23212610 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (15 mg, oral)
Number of subjects: 0
Study 23212610 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenous and oral)
Number of subjects: 0
Study 21654521 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 15 mg/kg intravenously on day 1 of the 2‐week cycle and IFN‐α thrice weekly at 5 MU/m subcutaneously during cycle 1, increased to 10 MU/m during cycle 2.
Number of subjects: 25
Study 21654521 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab and IFN‐α combination therapy
Number of subjects: 25
Study 21654521 — intervention group
Group type: COMPARATOR
Intervention: IFN‐α
Number of subjects: 25
Study 21654521 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 25
Study 21654521 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab and IFN‐α
Number of subjects: 25
Study 19344357 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic product containing antioxidative Lactobacillus fermentum ME‐3, Lact. paracasei 8700:2 and Bifidobacterium longum 46 with Raftilose P95
Number of subjects: 53
Study 19344357 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 53
Study 15811062 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector device (n=16)
Number of subjects: 38
Study 15811062 — intervention group
Group type: COMPARATOR
Intervention: Dentsply device at reduced power setting (n=22)
Number of subjects: 38
Study 15811062 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 38
Study 12459402 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead chelation therapy
Number of subjects: 111
Study 10627736 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 6 mg/kg once daily
Number of subjects: 75
Study 10627736 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin 5 mg/kg divided into twice daily doses
Number of subjects: 75
Study 8654073 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% Sodium Lauryl Sulfate (SLS) applied for 23 hours
Number of subjects: 20
Study 8654073 — intervention group
Group type: COMPARATOR
Intervention: 3 concentrations of Dimethylsulfoxide (DMSO) and 0.2 mol/l NaOH applied for 5 minutes
Number of subjects: 20
Study 1932669 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% ethanolamine oleate (EO)
Number of subjects: 45
Study 1932669 — intervention group
Group type: COMPARATOR
Intervention: 5% sodium morrhuate (SM)
Number of subjects: 45
Study 7255513 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg fenoprofen
Number of subjects: 10
Study 7255513 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg fenoprofen
Number of subjects: 10
Study 7255513 — intervention group
Group type: COMPARATOR
Intervention: Comparison with previous studies
Number of subjects: 10
Study 7255513 — intervention group
Group type: EXPERIMENTAL
Intervention: Haematological and biochemical values
Number of subjects: 10
Study 30472037 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week exercise program with dietary intervention
Number of subjects: 57
Study 30472037 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 57
Study 28867717 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (PRE)
Number of subjects: 49
Study 28867717 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose TWHF (DTW)
Number of subjects: 49
Study 28867717 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose TWHF (CTW)
Number of subjects: 49
Study 26139585 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii game computer with motivational support
Number of subjects: 600
Study 26139585 — intervention group
Group type: COMPARATOR
Intervention: Motivational support only (control)
Number of subjects: 600
Study 23815384 — intervention group
Group type: EXPERIMENTAL
Intervention: FOV 50°
Number of subjects: 0
Study 23815384 — intervention group
Group type: COMPARATOR
Intervention: FOV 100°
Number of subjects: 0
Study 21793388 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with modern rehabilitation training
Number of subjects: 120
Study 21793388 — intervention group
Group type: COMPARATOR
Intervention: Modern rehabilitation training
Number of subjects: 120
Study 19010579 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Emergency Team (MET) system
Number of subjects: 23
Study 19010579 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals (without MET system)
Number of subjects: 23
Study 17599843 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 microg of vaginal misoprostol on treatment day 1
Number of subjects: 473
Study 17599843 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of misoprostol if expulsion was incomplete on day 3
Number of subjects: 473
Study 17599843 — intervention group
Group type: COMPARATOR
Intervention: No intervention (neither indicator present) on day 8
Number of subjects: 473
Study 15240627 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable infusion rate (3 kcal/min for the first 15 min, then 0.71 kcal/min for the next 105 min)
Number of subjects: 16
Study 15240627 — intervention group
Group type: COMPARATOR
Intervention: Constant infusion rate (1 kcal/min from t = 0 to 120 min)
Number of subjects: 16
Study 15240627 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable infusion rate
Number of subjects: 16
Study 15240627 — intervention group
Group type: COMPARATOR
Intervention: Constant infusion rate
Number of subjects: 16
Study 12182779 — intervention group
Group type: EXPERIMENTAL
Intervention: Polylactic acid mesh implantation
Number of subjects: 39
Study 12182779 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (without mesh)
Number of subjects: 39
Study 9833910 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid
Number of subjects: 81
Study 9833910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 9833910 — intervention group
Group type: COMPARATOR
Intervention: Ursodeoxycholic acid and Placebo
Number of subjects: 81
Study 7661121 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE; 12.4 g/d)
Number of subjects: 74
Study 7661121 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE; 3 g/d)
Number of subjects: 74
Study 2759809 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 104
Study 2759809 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 104
Study 2759809 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 104
Study 799564 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol or Pindolol (acute and chronic administration)
Number of subjects: 2
Study 30967530 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense exercise (n = 35)
Number of subjects: 70
Study 30967530 — intervention group
Group type: COMPARATOR
Intervention: No exercise (n = 35)
Number of subjects: 70
Study 28287798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive anxiety sensitivity treatment (CAST) plus cognitive bias modification for anxiety sensitivity (CBM-I)
Number of subjects: 74
Study 28287798 — intervention group
Group type: COMPARATOR
Intervention: Health information condition plus sham cognitive bias modification for anxiety sensitivity (CBM)
Number of subjects: 74
Study 25953971 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based diabetes symptom self-management education (8 weekly in-home sessions + 8 biweekly support calls)
Number of subjects: 72
Study 25953971 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control condition
Number of subjects: 72
Study 22459260 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO‐SELF(©) Plus Pain Control Program (PCP), a 10-week intervention
Number of subjects: 39
Study 22459260 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 39
Study 22110714 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study 17923131 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate challenge test (CCCT)
Number of subjects: 110
Study 17923131 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous FSH ovarian reserve test (EFORT)
Number of subjects: 110
Study 17923131 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal AMH, basal FSH, basal inhibin B, antral follicle count (AFC), and basal volume of the ovaries
Number of subjects: 110
Study 17923131 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard IVF treatment
Number of subjects: 110
Study 16197663 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 4011
Study 16197663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4011
Study 11843734 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrronium 2 microg x kg(‐1)
Number of subjects: 0
Study 11843734 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0
Study 9584817 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (Carbo: > or = 150g/day for 3 days)
Number of subjects: 354
Study 9584817 — intervention group
Group type: EXPERIMENTAL
Intervention: Candy diet (six Snickers candy bars per day for 3 days)
Number of subjects: 354
Study 9584817 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (Ad Lib)
Number of subjects: 354
Study 9584817 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Carbo, Candy, Ad Lib)
Number of subjects: 354
Study 7703814 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Education drug education programme (5 consecutive years)
Number of subjects: 3000
Study 7703814 — intervention group
Group type: COMPARATOR
Intervention: Conventional school-based drug education (control group)
Number of subjects: 3000
Study 2697568 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicentre randomized clinical trials
Number of subjects: 0
Study 2697568 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent scientifically based research organizations
Number of subjects: 0
Study 2697568 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical industry involvement
Number of subjects: 0
Study 2697568 — intervention group
Group type: EXPERIMENTAL
Intervention: Critique of trial design
Number of subjects: 0
Study 2697568 — intervention group
Group type: EXPERIMENTAL
Intervention: CABRI trial
Number of subjects: 0
Study 1013671 — intervention group
Group type: EXPERIMENTAL
Intervention: mexiletine (250 mg 8‐hourly)
Number of subjects: 40
Study 1013671 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 30099547 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 22
Study 30099547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 26916879 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.4 to 2.4 mg/g nicotine, 9 to 13 mg tar)
Number of subjects: 403
Study 26916879 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Nicotine Content (5.2 mg/g nicotine, 9 mg tar)
Number of subjects: 403
Study 26916879 — intervention group
Group type: COMPARATOR
Intervention: Normal Nicotine Content (NNC) cigarettes (15.8 mg/g, 9 mg tar)
Number of subjects: 403
Study 26916879 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes
Number of subjects: 403
Study 24626998 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D implantation
Number of subjects: 98
Study 24626998 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D implantation with GFR <60 mL/min/1.73 m²
Number of subjects: 98
Study 24626998 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D implantation with GFR ≥60 mL/min/1.73 m²
Number of subjects: 98
Study 24626998 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D recipients with CI-AKI
Number of subjects: 98
Study 24626998 — intervention group
Group type: COMPARATOR
Intervention: CRT-D recipients without CI-AKI
Number of subjects: 98
Study 24626998 — intervention group
Group type: EXPERIMENTAL
Intervention: CI-AKI as a risk factor
Number of subjects: 98
Study 22320241 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 132
Study 22320241 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 132
Study 19786879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing-aid use for 6 months
Number of subjects: 32
Study 19786879 — intervention group
Group type: COMPARATOR
Intervention: Long-term hearing-aid use
Number of subjects: 32
Study 19786879 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual task with emotionally positive and neutral pictures
Number of subjects: 32
Study 18795715 — intervention group
Group type: EXPERIMENTAL
Intervention: M2-pyruvate-kinase concentration measurement
Number of subjects: 0
Study 15729065 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCfoot+calf and aspirin (75 mg)
Number of subjects: 41
Study 15729065 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (75 mg) alone
Number of subjects: 41
Study 11909881 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise session (ES) - 40 minutes of cycling at 75% maximum heart rate
Number of subjects: 30
Study 11909881 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise session (RS) - 3 sets of 10 repetitions of eight exercises
Number of subjects: 30
Study 11909881 — intervention group
Group type: COMPARATOR
Intervention: Control session (CS) - no exercise
Number of subjects: 30
Study 9748878 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of berodual sol 3.5 ml/day (1.75 mg phenoterol + 0.875 mg ipratropium bromide)
Number of subjects: 0
Study 9748878 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of berodual sol 7 ml/day (3.5 mg phenoterol + 1.75 mg ipratropium bromide)
Number of subjects: 0
Study 7853434 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 30 mg/kg/day
Number of subjects: 79
Study 7853434 — intervention group
Group type: COMPARATOR
Intervention: Nalidixic acid 60 mg/kg/day
Number of subjects: 79
Study 2668464 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure readings
Number of subjects: 2000
Study 2668464 — intervention group
Group type: COMPARATOR
Intervention: Office blood pressure readings
Number of subjects: 2000
Study 1233124 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy and pyloroplasty (SGV+D)
Number of subjects: 448
Study 1233124 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy (PCV) without drainage
Number of subjects: 448
Study 31751936 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated sodium bicarbonate (ENT)
Number of subjects: 14